NZ Population Health Congress speaks the truth: “The reality is that the provisions proposed in the TPPA will allow patent-holding pharmaceutical companies to interfere with PHARMAC’s ability to source the most affordable medicines. This will lead either to higher costs to patients or to reduced funding available from the Vote Health Budget for other health areas – probably both. “Interestingly, the industry talks about how great it will be for everyone when its economic interests are protected and words like innovative, pioneering, life-saving, strengthen, advanced and high standard abound. However, one thing it never mentions is the issue of the affordability of medicines to the public.”
Posted on: Tue, 07 Oct 2014 09:15:21 +0000
Trending Topics
Recently Viewed Topics
© 2015